Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06903468

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions

Led by University of Florida · Updated on 2025-12-15

50

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating a new technique for marking the surgical cavity after tumor removal in breast cancer patients undergoing breast conservation surgery with oncoplastic reconstruction. This approach aims to improve the accuracy of identifying cavity margins on CT scans used for planning and delivering radiotherapy. The marking system may also help determine precise margins for patients who need additional surgery due to close or positive margins. The study involves using a novel cavity marking technique during surgery, where clips are placed in a specific clockwise pattern around the tumor bed to mark the cavity margins. The marking differs slightly between the left and right breasts but consistently includes one large clip and several medium-sized clips placed at defined positions. This procedure is performed on all participants during their breast conservation surgery. Participants will be followed to evaluate how confident clinicians are in identifying the cavity on imaging within 8 weeks after surgery or chemotherapy. Researchers will also track the percentage of patients needing additional surgery within 7 to 14 days after the initial surgery and monitor local disease recurrence, overall survival, and recurrence-free survival rates up to 2 years post-surgery. Throughout the study, participants will undergo assessments related to imaging and clinical outcomes to determine the usefulness of the cavity marking technique.

CONDITIONS

Brief Title

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisions

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 63 18 years of age
  • Pathological diagnosis of non-invasive ductal carcinoma in-situ (DCIS) or invasive breast cancer, Tis-T3N0-3M0
  • Planning to undergo or have undergone breast conservation surgery with oncoplastic reconstruction including cavity marking
  • ECOG performance status of 0 or 1
  • Able to provide written informed consent and comply with study procedures
  • No more than one active malignancy at enrollment (exceptions allowed per physician approval)
  • If of childbearing potential, using adequate contraception and advised to avoid pregnancy during surgery and radiotherapy
Not Eligible

You will not qualify if you...

  • Not recommended for or declined adjuvant radiotherapy
  • Prior ipsilateral breast surgery with identifiable surgical clips
  • Confirmed pregnancy or breastfeeding
  • Any disease or condition that contraindicates study therapy or might affect results or increase risk, as judged by physician
  • Prisoners, involuntarily incarcerated, or under compulsory treatment for psychiatric or physical illness

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery

Duration - Day of surgery

Participants undergo breast conservation surgery with oncoplastic reconstruction including the novel cavity marking technique.

1 surgical visit (in-person)

Post-operative Follow-up

Duration - 7 to 14 days post-surgery

Participants are monitored for the need of re-excision and recovery after surgery.

1 follow-up visit (in-person)

Treatment

Duration - Approximately 4 to 6 months depending on chemotherapy schedule

Participants receive adjuvant radiotherapy following surgery with cavity marking.

Visits scheduled according to radiotherapy and chemotherapy treatment plan

Follow-up

Duration - Up to 2 years post-surgery

Participants are monitored for local disease recurrence and overall survival outcomes.

Periodic visits for up to 2 years

Trial Site Locations

Total: 1 location

1

University of Florida

Gainesville, Florida, United States, 32608

Actively Recruiting

Loading map...

Research Team

S

Stephanie Portillo

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Investigating The Role of Key Non-coding RNA(s) in Breast Ca...

Breast Cancer

Actively Recruiting

1 location

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Bre...

Breast Cancer

Actively Recruiting

1 location

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here